Norton Jenna M, Dodson Jennifer L, Newman Diane K, Rogers Rebecca G, Fairman Andrea D, Coons Helen L, Star Robert A, Bavendam Tamara G
Division of Kidney, Urologic, and Hematologic Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 6707 Democracy Blvd, Office 6081, MSC 5458, Bethesda, MD, 20892-5458, USA.
Department of Urology, Johns Hopkins University, Baltimore, MD, USA.
Int Urogynecol J. 2017 Sep;28(9):1295-1307. doi: 10.1007/s00192-017-3400-x. Epub 2017 Jul 3.
Urinary incontinence (UI)-defined as a complaint of involuntary loss of urine-is common in women, with major public health, financial, and quality of life (QoL) implications. Despite the high toll of UI and the availability of effective conservative treatments, many women with UI do not seek care. Those who do often continue to experience symptoms. Improving UI treatment may require a comprehensive approach to urology research, including a broad set of potentially influential factors beyond biologic.
To explore the effects of nonbiologic factors (NBF) on UI management and treatment response, the National Institute of Diabetes and Digestive and Kidney Diseases convened a workshop for clinical and psychosocial researchers. Participants proposed a UI treatment pathway: recognizing the problem, willingness to seek treatment, access to care, receiving quality treatment, engaging in self-management, and adhering to chosen treatments; discussed potential NBFs that may affect the pathway; and identified areas for future research. After the meeting, a rapid literature review was conducted to assess the current state of research on NBFs in women with UI.
Participants identified several patient-level NBFs that may influence the UI management pathway, including QoL and perceived bother; stigma, shame, and embarrassment; knowledge and perceptions; social determinants of health; cultural and language characteristics; personal characteristics and skills; and physical abilities. Additionally, participants acknowledged that provider- and system-level factors also play a role and likely interact with patient-level factors.
NBFs that potentially affect the UI management pathway are not well understood, and a comprehensive, interdisciplinary approach to research is needed to understand and appropriately support effective UI treatment.
尿失禁(UI)被定义为非自愿性漏尿的主诉,在女性中很常见,对公共卫生、经济和生活质量(QoL)有重大影响。尽管尿失禁造成了高昂代价且有有效的保守治疗方法,但许多尿失禁女性并未寻求治疗。那些寻求治疗的女性往往仍有症状。改善尿失禁治疗可能需要对泌尿外科研究采取综合方法,包括一系列超出生物学范畴的潜在影响因素。
为探讨非生物学因素(NBF)对尿失禁管理和治疗反应的影响,美国国立糖尿病、消化和肾脏疾病研究所召集了临床和社会心理研究人员参加研讨会。参与者提出了一条尿失禁治疗途径:认识问题、寻求治疗的意愿、获得医疗服务、接受高质量治疗、进行自我管理以及坚持所选治疗;讨论了可能影响该途径的潜在非生物学因素;并确定了未来研究领域。会议结束后,进行了快速文献综述,以评估尿失禁女性非生物学因素的当前研究状况。
参与者确定了几个可能影响尿失禁管理途径的患者层面的非生物学因素,包括生活质量和感知困扰;耻辱感、羞耻感和尴尬感;知识和认知;健康的社会决定因素;文化和语言特征;个人特征和技能;以及身体能力。此外,参与者承认提供者和系统层面的因素也起作用,并且可能与患者层面的因素相互作用。
对可能影响尿失禁管理途径的非生物学因素了解不足,需要采取综合、跨学科的研究方法来理解并适当支持有效的尿失禁治疗。